MASECO Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205K Sell
7,302
-206
-3% -$5.48K 0.01% 106
2025
Q4
$187K Buy
+7,508
New +$189K 0.01% 96
2025
Q3
Sell
-9,571
Closed -$232K 443
2025
Q2
$232K Buy
+9,571
New +$223K 0.01% 99

Other funds holding PFE

MASECO Private Wealth's PFE Position: Q1 2026 in Review

MASECO Private Wealth reduced its Pfizer (PFE) stake by 2.7% in Q1 2026, selling an estimated $5.48K and leaving 7,302 shares worth $205K. The position accounts for 0.01% of the portfolio, ranked #106.

MASECO Private Wealth first reported a position in PFE in Q2 2025 and has held it in 3 quarters since. The position peaked at $232K in Q2 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • MASECO Private Wealth held 7,302 shares of Pfizer worth $205K as of Q1 2026.
  • MASECO Private Wealth sold 206 Pfizer shares in Q1 2026, an estimated $5.48K.
  • Pfizer made up 0.01% of MASECO Private Wealth's portfolio in Q1 2026, its #106 holding.
  • MASECO Private Wealth first reported a position in Pfizer in Q2 2025 and has held it in 3 quarters since.
  • MASECO Private Wealth's Pfizer position peaked at $232K in Q2 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on MASECO Private Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.